Introduction
============

The majority of *Mycoplasma (M) pneumoniae* respiratory infection are self-limited. An estimated 3--13% of infected persons with infection experience pneumonia, and the remains are manifested as upper respiratory tract infection \[[@B3]; [@B36]; [@B37]; [@B1]\]. Therefore pathological specimens of human *M. pneumoniae* pneumonia are rarely obtained. Pathological descriptions of this pneumonia include marked plasma cell-rich lymphocytic infiltration in peribronchial and perivascular areas, with accumulations of macrophages, neutrophils, and lymphocytes in the alveolar spaces, foci of interstitial pneumonia, and hyperplasia of type II pneumocytes ([@B8]; [@B6]; [@B14]; [@B2]). Bronchiolitis and alveolitis with dense mononuclear cells infiltration, epithelioid cell granulation tissue filling alveolar ducts, organizing alveolar exudates, and hyaline membranes are characteristic findings in fulminant *M. pneumoniae* pneumonia ([@B12]; [@B21]; [@B10]; [@B4]; [@B11]). On the other hand, the patterns of *M. pneumoniae* pneumonia on chest radiography are non-specific segmental or lobar consolidation, bilateral diffuse reticular interstitial infiltrates ([@B19]). Computed tomography (CT) findings of this pneumonia are bronchovascular thickening, centrilobular nodules, ground-glass attenuation, or air-space consolidation ([@B31]; [@B35]; [@B20]; [@B16], [@B15]). However, there has been little report radiological--pathological correlation in human *M. pneumoniae* pneumonia ([@B9]). This review focuses on radiological--pathological correlation of *Mycoplasma* pneumonia in mice and humans, and the changes of pulmonary involvement patterns reflecting by host cell-mediated immunity (CMI) levels.

Radiological--Pathological Correlation in Animal Models
=======================================================

The pathogenesis of *Mycoplasma* infection has been studied in animal model. The pathological changes and patterns are similar to that seen in experimental infection in hamsters or mice. In **Figures [1A,B](#F1){ref-type="fig"}**, *M. pulmonis* inoculated mice model reveals that pathological changes consist with (1) peribronchial and perivascular mononuclear cells accumulation throughout large to small airways, (2) cellular bronchiolitis with lumen exudates and mononuclear cell in airway walls extending into adjacent alveoli ([@B29]). Next, inflated lung specimens of *M. pulmonis* inoculated mice were prepared by [@B9] method ([@B13]). Radiological findings of the infected lungs disclosed thickening of bronchovascular bundles, centrilobular nodules, and ground-glass opacities (**Figures [1C,D](#F1){ref-type="fig"}**). Pathological changes clearly reflect to radiological findings in *M. pulmonis* inoculated mice.

![***Mycoplasma pulmonis* infected mice, 2 weeks after inoculation.** Low-magnification photomicrographs of non-infected lung **(A)** and infected lung **(B**; HE x17). **(C)** Radiograph of inflated lung of infected mice reveals bronchovascular bundles thickening, nodules, and ground-glass attenuation. **(D)** Radiograph of thin-sliced lung of infected mice shows nodules with centrilobular distribution and consolidation. Reproduced with permission from [@B25].](fmicb-07-00695-g001){#F1}

Immunomodulators Change the Pathological Pattern of *Mycoplasma* Pneumonia
==========================================================================

The role of T cells in the pathogenesis of *M. pneumoniae* infection can be defined by the apparent correlation of delayed-type hypersensitivity (DTH) skin reaction to *M. pneumoniae* in humans with the severity of disease ([@B17]). To elucidate immune-pathological mechanism of *Mycoplasma* pneumonia, the therapeutic effects of interleukin-2 (IL-2), cyclosporine A (CYA), and prednisolone (PSL) on mice model ([@B29]). Mice were intra-nasally inoculated with *M. pulmonis* and were treated with IL-2, CYA, and PSL every day between Days 3 and 9, and were killed at Day 14. IL-2 is immunomodulator, especially up-regulate CMI, and CYA is immunosuppressant, especially down-regulate CMI of the host. PSL is a more powerful immunosuppressant. CMI level of the host was assessed by skin test by sheep red blood cell (SRBC). Peribronchial and perivascular mononuclear cell cuffing and accumulation of macrophages at the end of bronchiole were exacerbated in IL-2 treated mice (**Figures [2](#F2){ref-type="fig"}** and **[3](#F3){ref-type="fig"}**). On the other hand, prominent intra-alveolar inflammatory cell infiltration and faint peribronchial and perivascular mononuclear cell cuffing were observed on CYA or PSL treated mice (**Figures [2](#F2){ref-type="fig"}** and **[3](#F3){ref-type="fig"}**). CMI to SRBC was increased in IL-2 treated mice, however, decreased in CYA or PSL treated mice. Another *M. pneumoniae* inoculated mice model exhibited host-dependent infection-related airway obstruction and airway hyperresponsiveness associated with chemokine and T-helper type 1 pulmonary host response and not T-helper type 2 response after *M. pneumoniae* infection ([@B5]). Recently, the severity of the *M. pneumoniae* pneumonia seemed to depend on the host innate immunity to the *M. pneumoniae*, which might be accelerated by antecedent *M. pneumoniae* exposure (re-exposure or latent respiratory infection) through up-regulation of Toll-like receptor 2 expression on bronchial epithelial cells and alveolar macrophages using mice model ([@B23], [@B22]).

![**Low-magnification photomicrographs of lung, 2 weeks after *M. pulmonis* inoculation (HE x17). (A)** Mice without treatment. **(B)** Mice treated with interleukin-2, showing marked peribronchial and perivascular lymphocyte cuffing, and no intra-alveolar inflammation. **(C)** Mice treated with PSL, disclosing predominance of intra-alveolar inflammatory cell infiltration, and a little peribronchial and perivascular lymphocyte cuffing. Reproduced with permission from [@B34].](fmicb-07-00695-g002){#F2}

![**Pathological observation of lung from *M. pulmonis* infected mice (HE x170). (A)** Mice without treatment. **(B)** Mice treated with interleukin-2, showing marked peribronchial lymphocyte cuffing and macrophage accumulation at the end bronchiole. **(C)** Mice treated with PSL, disclosing predominant intra-alveolar inflammatory cell Infiltration and faint perivascular lymphocyte cuffing. Reproduced with permission from [@B34].](fmicb-07-00695-g003){#F3}

Radiological Assessment of *M. pneumoniae* Pneumonia
====================================================

The most common radiographic findings consist of unilateral or bilateral areas of air-space consolidation and ground-glass opacities. However, the findings are variable and can include reticular or nodular opacities. Associated features include bronchial wall thickening and occasionally small pleural effusion. CT shows more accurately the presence and extent of centrilobular nodules, the lobular distribution of ground-glass opacities and a small amount of pleural effusion not visible on chest radiograph. Typical findings of adult *M. pneumoniae* pneumonia on chest radiograph and CT are demonstrated in **Figure [4](#F4){ref-type="fig"}**. The findings of bronchiolitis and lobular consolidation seen in histopathological specimens were seldom apparent on radiography but were commonly evident on CT. The most distinct abnormality seen on CT consisted of poorly defined centrilobular nodules, suggesting bronchiolitis. A study using high-resolution CT shows the most frequent chest radiologic finding was air-space consolidation, seen in 86% of 28 patients, and most commonly involving the lower lobe and nodular opacities were detected in 14 patients ([@B20]). The areas of patchy air-space consolidation or ground-glass attenuation frequently had a lobular distribution, a characteristic pathological feature of bronchopneumonia. Although the most common abnormalities were thickening of the axial interstitium appearing bronchovascular bundles thickening on radiograph and CT ([@B31]).

![***Mycoplasma pneumoniae* pneumonia in human. (A)** Chest x-ray shows infiltrates in the right lower lobe. **(B)** Consolidation (^∗^) and bronchovascular bundles thickening (↑) on CT scan. Reproduced with permission from [@B28].](fmicb-07-00695-g004){#F4}

Pathological Findings in Open Lung Biopsy
=========================================

*Mycoplasma pneumoniae* organism selectively attaches airway ciliated epithelial cells ([@B33]) and therefore the pathological findings are usually limited to the airway walls as far down as small airways; the respiratory bronchioles. Histopathologically, *M. pneumoniae* pneumonia is characterized by acute cellular bronchiolitis with edematous and ulcerative lesions of bronchial walls and by peribronchial and perivascular interstitial opacities containing lymphocytes, plasma cells, and macrophages. The wall of bronchioles contains mononuclear cell and macrophage with a centrilobular distribution. In cases of severe pneumonia, diffuse alveolar damage with fibrinous exudates and hyaline membrane formation ([@B21]; [@B11]). Histopathological observation of open lung biopsy specimens from middle aged woman in recovery phase of *M. pneumoniae* pneumonia are showed in **Figure [5](#F5){ref-type="fig"}**. Low-magnification photomicrographs of small airways shows cellular bronchiolitis with thickening walls and exudates in the lumen. High-magnification of alveolar area discloses intra-alveolar inflammatory-cell infiltration and organizing pneumonia with granulation tissue filling alveolar ducts.

![**Photomicrograph of open lung biopsy specimens in recovery phase of patients with *M. pneumoniae* pneumonia.** Low-magnification views of small airways show cellular bronchiolitis and exudate in the lumen **(A,B)**. High-magnification of alveolar area disclose stuffed alveoli with exudate, fibrin, neutrophil, and granulation tissue in alveolar duct (^∗^; **C,D**). Reproduced with permission from [@B25].](fmicb-07-00695-g005){#F5}

Summary of pathological--radiological correlations and frequency of three major CT findings in 91 cases of adult *M. pneumoniae* pneumonia were shown in **Figure [6](#F6){ref-type="fig"}**. It was reported that *M. pneumoniae* pneumonia in the recovery phase showed predominantly centrilobular nodular patterns, which disclosed immunological inflammation remaining in the small airways ([@B31]). However, some patients demonstrated centrilobular nodules in the early phase of the pneumonia (**Figure [7](#F7){ref-type="fig"}**), which mimicking T-helper type 1 pulmonary host response in the mice model ([@B29]).

![**Summary of radiological--pathological correlation in adult *M. pneumoniae* pneumonia.** Reproduced with permission from [@B26].](fmicb-07-00695-g006){#F6}

![**Computed tomography of centrilobular nodules predominant pattern in two patients with *M. pneumoniae* pneumonia.** Reproduced with permission from [@B27].](fmicb-07-00695-g007){#F7}

Host CMI and Radiological Pattern
=================================

The CMI of the host plays an important role in the development of *M. pneumoniae* pneumonia. *M. pneumoniae* pneumonia in patients with immunodeficiency syndrome had a rack of radiological chest findings ([@B7]). On the other hand, the radiographic appearance of *M. pneumoniae* pneumonia in patients with sarcoidosis showed a bilateral reticulonodular pattern ([@B19]). [@B10] reported a married couple who developed *M. pneumoniae* pneumonia at the same time, and whose severity of pneumonia, radiological findings and serum soluble IL-2 receptor levels were marked different between wife and husband. The wife developed acute respiratory failure with high serum levels of soluble IL-2 receptor, on the other hand, the husband suffered from pneumonia with a moderate elevation of soluble IL-2 receptor. The difference may be reflected in the serum soluble IL-2 receptor levels, a marker of T cell activation *in vivo*. Serum IL-18 levels in patients with severe *M. pneumoniae* pneumonia were higher than those in mild cases ([@B32]), which suggested IL-18 and T-helper 1(Th1) cytokines may play a significant role in developing pneumonia. And IL-18 levels of pleural effusion in pediatric patients also elevated ([@B18]). In human *M. pneumoniae* pneumonia, positive rate of purified protein derivative (PPD) test in patients with nodular opacities predominant pattern on CT (group N) was higher than that in patients with air-space consolidation or ground-glass opacities predominant pattern on CT (group C) in *M. pneumoniae* pneumonia ([@B30]). The PPD skin reaction; tuberculin skin test, is used not only to confirm past infection of *Mycobacterium tuberculosis* but also to determine the CMI of the host. In other words, patients with nodular opacities predominant on CT showed a more marked response to PPD than those with air-space consolidation predominant pattern on CT.

Bronchiolitis Obliterans Following *M. pneumoniae* Infection
============================================================

The presence of centrilobular nodules in a patchy distribution is characteristic of infectious bronchiolitis, allowing distinction from non-infectious causes of bronchiolitis, which usually have a diffuse distribution throughout both lungs ([@B2]; [@B4]). We experienced a woman suffered *M. pneumoniae* infection. She complained dyspnea 2 months after the infection. Her chest radiograph and CT revealed overinflation with no centriacinar nodules (**Figure [8](#F8){ref-type="fig"}**). Her pulmonary function test revealed a vital capacity of 2469 ml, an forced effort in 1 s; FEV1 of 940 ml, and FEV1/FVC ratio of 41%, a V50/V25 ratio of 2.01, and a residual volume/total lung capacity ratio of 47%. ^99m^Tc-MAA perfusion scan revealed slight defect and ^81m^Kr-aerosol ventilation scan demonstrated prominent multiple defects, suggesting bronchiolitis obliterans. Centrilobular nodule of under 500 μm could not detected in high-resolution CT scan, therefore pulmonary functions are useful technique for detecting subtle small airway abnormality.

![**Bronchiolitis obliterans following *M. pneumoniae* infection. (A)** Chest X-ray showing normal. **(B)** ^99m^Tc-MAA perfusion scan revealing slight defect. **(C)** ^81m^Kr-aerosol ventilation demonstrating prominent multiple defects throughout the lung field. Reproduced with permission from [@B25].](fmicb-07-00695-g008){#F8}
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